论文部分内容阅读
目前吸入性皮质类固醇激素广泛应用于支气管哮喘和慢性阻塞性肺部疾病的长期治疗。已有研究表明长期应用吸入性皮质类固醇激素治疗绝经后哮喘妇女患者,可引起患者腰椎骨密度(BMD)减少。本研究旨在比较阿仑膦 (Alendronate)和阿法骨化醇(Alfacalcideol)治疗因上述原因引起BMD减少的疗效评价。
Currently inhaled corticosteroids are widely used in the long-term treatment of bronchial asthma and chronic obstructive pulmonary disease. Studies have shown that long-term use of inhaled corticosteroids in patients with postmenopausal women with asthma can cause lumbar spine bone mineral density (BMD) reduction. This study was designed to compare the efficacy of Alendronate and Alfacalcideol in the treatment of patients with BMD reductions caused by these factors.